These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 18958402

  • 1. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
    Garbuzenko OB, Saad M, Betigeri S, Zhang M, Vetcher AA, Soldatenkov VA, Reimer DC, Pozharov VP, Minko T.
    Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
    [Abstract] [Full Text] [Related]

  • 2. Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice.
    Mainelis G, Seshadri S, Garbuzenko OB, Han T, Wang Z, Minko T.
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):345-54. PubMed ID: 23530772
    [Abstract] [Full Text] [Related]

  • 3. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM, Jie J, Zhang Y, Liu H, Peng LP.
    Biochem Biophys Res Commun; 2017 Dec 02; 493(4):1430-1437. PubMed ID: 28958938
    [Abstract] [Full Text] [Related]

  • 4. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J, Lee A, Lu Y, Lee RJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):329-35. PubMed ID: 17275230
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug.
    Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T.
    J Control Release; 2006 Aug 28; 114(2):153-62. PubMed ID: 16889867
    [Abstract] [Full Text] [Related]

  • 6. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y, Nakamura A, Arai S, Kawano K, Maitani Y, Yonemochi E.
    J Liposome Res; 2015 Aug 28; 25(4):279-86. PubMed ID: 25543847
    [Abstract] [Full Text] [Related]

  • 7. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J, Yang SJ, Wang JC, Yang LJ, Xu ZZ, Yang T, Liu XY, Zhang Q.
    Eur J Pharm Biopharm; 2010 Oct 28; 76(2):170-8. PubMed ID: 20600887
    [Abstract] [Full Text] [Related]

  • 8. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X, Feng S, Chi Y, Liu J, Sun K, Guo C, Wu Z.
    Drug Deliv; 2018 Nov 28; 25(1):900-908. PubMed ID: 29644882
    [Abstract] [Full Text] [Related]

  • 9. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
    Paliwal SR, Paliwal R, Mishra N, Mehta A, Vyas SP.
    Curr Cancer Drug Targets; 2010 May 28; 10(3):343-53. PubMed ID: 20370682
    [Abstract] [Full Text] [Related]

  • 10. Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.
    Meissner JM, Toporkiewicz M, Czogalla A, Matusewicz L, Kuliczkowski K, Sikorski AF.
    J Control Release; 2015 Dec 28; 220(Pt A):515-528. PubMed ID: 26585505
    [Abstract] [Full Text] [Related]

  • 11. Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.
    Gaspar MM, Radomska A, Gobbo OL, Bakowsky U, Radomski MW, Ehrhardt C.
    J Aerosol Med Pulm Drug Deliv; 2012 Dec 28; 25(6):310-8. PubMed ID: 22857016
    [Abstract] [Full Text] [Related]

  • 12. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
    Chen H, Qin Y, Zhang Q, Jiang W, Tang L, Liu J, He Q.
    Eur J Pharm Sci; 2011 Sep 18; 44(1-2):164-73. PubMed ID: 21782939
    [Abstract] [Full Text] [Related]

  • 13. Systemic delivery and pre-clinical evaluation of nanoparticles containing antisense oligonucleotides and siRNAs.
    Zhang C, Newsome JT, Mewani R, Pei J, Gokhale PC, Kasid UN.
    Methods Mol Biol; 2009 Sep 18; 480():65-83. PubMed ID: 19085118
    [Abstract] [Full Text] [Related]

  • 14. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.
    Int J Pharm; 2009 Dec 01; 382(1-2):254-61. PubMed ID: 19666094
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo.
    Xiong XB, Huang Y, Lu WL, Zhang H, Zhang X, Zhang Q.
    Pharm Res; 2005 Jun 01; 22(6):933-9. PubMed ID: 15948037
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A, Salmaso S, Eldar-Boock A, Ben-Shushan D, Ferber S, Tiram G, Shmeeda H, Landa-Rouben N, Leor J, Caliceti P, Gabizon A, Satchi-Fainaro R.
    J Control Release; 2015 Jun 28; 208():106-20. PubMed ID: 25869964
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.
    Hattori Y, Arai S, Kikuchi T, Ozaki KI, Kawano K, Yonemochi E.
    J Drug Target; 2016 Apr 28; 24(4):309-317. PubMed ID: 26234899
    [Abstract] [Full Text] [Related]

  • 19. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X, Wang Q, Qin L, Fu H, Fang Y, Han B, Duan Y.
    Drug Deliv; 2016 Oct 28; 23(8):2936-2945. PubMed ID: 26739487
    [Abstract] [Full Text] [Related]

  • 20. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL, Simões S, de Almeida LP, Pelisek J, Culmsee C, Wagner E, Pedroso de Lima MC.
    J Gene Med; 2007 Mar 28; 9(3):170-83. PubMed ID: 17351968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.